Viability of microorganisms in bags of cytotoxic drugs

Journal of Oncology Pharmacy Practice

Volumn 6, Issue 4, 2001, Pages 167-171

  Favier, Bertrand ^a   Latour, Jean François ^a   Fuhrmann, Christine ^a  

^a CENTRE LÉON BÉRARD   (France)

Author keywords

Candida albicans; Cytotoxic agent; Escherichia coli; Pseudomonas aeruginosa; quality assurance; Staphylococcus aureus; Staphylococcus epidermidis; viability

Indexed keywords

EID: 84990385615     PISSN: 10781552     EISSN: None     Source Type: Journal    
DOI: 10.1177/107815520100600405     Document Type: Article

References (7)

1. Hamilton-Miller JM. Antimicrobial activity of 21 antineoplastic agents. Br J Cancer. 1984; 49: 367-369.
2. Kramer I, Wenchel HM. Viability of microorganisms in antineoplastic drug solutions. Eur J Hosp Pharm. 1991; 1: 14-19.
3. Kramer I, Wenchel HM. Wachstumsverhalten ausgew Ählter mikroorganismen in zytostatika-zuberreitungen. Krankenhauspharmazie. 1988; 11: 439-442.
4. Kramer I. Viability of microorganisms in novel antineoplastic and antiviral drug solutions. J Oncol Pharm Pract. 1998; 4: 32-37.
5. Holmes J, Kubey WY, Loves D. Viability of microorganisms in fluorouracil and cisplatin small-volume injections. Am J Hosp Pharm. 1988; 45: 1089-1091.
6. Patel K, Craig S, McBride M, Papelu N. Microbial inhibitory properties and stability of topotecan hydrochloride injection. Am J Health-Syst Pharm. 1998; 55: 1584-1587.
7. D’Angio R, Quercia R, Treiber N, McLaughlin J, Klimek J. The growth of microorganisms in total parenteral nutrition admixtures. J Parenter Enteral Nutr. 1987; 11: 394-397.